Jackson Creek Investment Advisors LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1831003
CASTLE ROCK, CO
Position in REGN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$577,934
-$4,827 QoQ
Shares Held
748
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jackson Creek Investment Advisors LLC holds $9,711,003 across 17 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
6,037 | $1,908,235 | |
| 2 | TVTX |
Travere Therapeutics, Inc.
|
30,801 | $1,749,804 | |
| 3 | TBPH |
Theravance Biopharma, Inc.
|
85,508 | $1,453,636 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
4,740 | $1,142,197 | |
| 5 | RPRX |
Royalty Pharma plc
|
12,743 | $714,500 | |
| 6 | VCEL |
Vericel Corp
|
14,393 | $640,344 | |
| 7 | WVE |
Wave Life Sciences, Inc.
|
92,662 | $538,366 | |
| 8 | JANX |
Janux Therapeutics, Inc.
|
34,719 | $533,283 |
All Filings in REGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $577,934 | 748 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $582,761 | 755 | Shares | Sole | 2026-02-09 | |
| 2024-12-31 | $339,069 | 476 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $500,390 | 476 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $547,586 | 521 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $525,519 | 546 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $591,089 | 673 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $572,780 | 696 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $554,712 | 772 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,233,326 | 1,501 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,083,677 | 1,502 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,153,857 | 1,675 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $998,418 | 1,689 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $684,451 | 980 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,192,941 | 1,889 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $827,281 | 1,367 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $788,099 | 1,411 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $668,546 | 1,413 | Shares | Sole | 2021-05-27 | |
| 2020-12-31 | $660,411 | 1,367 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $769,137 | 1,374 | Shares | Sole | 2020-11-09 | |
| No filing history on record for this holder in this stock. | ||||||